Published in Ann Thorac Surg on August 01, 1992
Long-term survival following endoscopic and surgical treatment of high-grade dysplasia in Barrett's esophagus. Gastroenterology (2007) 2.86
American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology (2011) 2.50
Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma. Gut (1998) 2.38
Observer variation in the diagnosis of superficial oesophageal adenocarcinoma. Gut (2002) 2.16
The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review. Am J Gastroenterol (2012) 1.81
Outcome of surgical treatment for early adenocarcinoma of the esophagus or gastro-esophageal junction. Virchows Arch (2005) 1.74
The cost effectiveness of radiofrequency ablation for Barrett's esophagus. Gastroenterology (2012) 1.65
Cost effectiveness of detecting Barrett's cancer. Gut (1996) 1.63
Barrett's esophagus with high-grade dysplasia. An indication for prophylactic esophagectomy. Ann Surg (1996) 1.61
Chromosomal imbalances in Barrett's adenocarcinoma and the metaplasia-dysplasia-carcinoma sequence. Am J Pathol (2000) 1.57
The rationale for esophagectomy as the optimal therapy for Barrett's esophagus with high-grade dysplasia. Ann Surg (1996) 1.39
Genetic alterations in Barrett esophagus and adenocarcinomas of the esophagus and esophagogastric junction region. Am J Pathol (1998) 1.36
What is the best management strategy for high grade dysplasia in Barrett's oesophagus? A cost effectiveness analysis. Gut (2004) 1.29
Cost-effectiveness of photodynamic therapy for treatment of Barrett's esophagus with high grade dysplasia. Dig Dis Sci (2003) 1.07
Diagnosis and grading of dysplasia in Barrett's oesophagus. J Clin Pathol (2006) 0.93
Preoperative Cyfra21-1 and SCC-Ag serum titers predict survival in patients with stage II esophageal squamous cell carcinoma. J Transl Med (2012) 0.93
High grade dysplasia: surveillance, mucosal ablation, or resection? World J Surg (2003) 0.91
Can extent of high grade dysplasia in Barrett's oesophagus predict the presence of adenocarcinoma at oesophagectomy? Gut (2003) 0.89
miR-200 family expression is downregulated upon neoplastic progression of Barrett's esophagus. World J Gastroenterol (2011) 0.88
Dysplasia and aneuploidy as markers of malignant degeneration in Barrett's oesophagus. The Rotterdam Oesophageal Tumour Study Group. Gut (1994) 0.86
Photodynamic therapy for Barrett's esophagus with high-grade dysplasia: a cost-effectiveness analysis. Can J Gastroenterol (2007) 0.86
Patient preferences for the management of high-grade dysplasia in Barrett's esophagus. Dig Dis Sci (2005) 0.85
Role of surveillance in intestinal metaplasia of the esophagus and gastroesophageal junction. World J Surg (2003) 0.85
Predictors of esophageal stricture formation post endoscopic mucosal resection. Clin Endosc (2014) 0.84
Quality of life in patients with various Barrett's esophagus associated health states. Health Qual Life Outcomes (2006) 0.84
Prophylactic esophagectomy in Barrett esophagus with high-grade dysplasia. Langenbecks Arch Surg (2003) 0.82
Endoscopic management of Barrett's esophagus: advances in endoscopic techniques. Dig Dis Sci (2012) 0.78
Statins and aspirin for chemoprevention in Barrett's esophagus: results of a cost-effectiveness analysis. Cancer Prev Res (Phila) (2013) 0.77
Barrett's esophagus--Who, how, how often and what to do with dysplasia? Can J Gastroenterol (2006) 0.75
Endoscopic ablation is a cost-effective cancer preventative therapy in patients with Barrett's esophagus who have elevated genomic instability. Endosc Int Open (2016) 0.75
Management controversies in Barrett's oesophagus. J Gastroenterol (2013) 0.75
Increasing incidence of adenocarcinoma of the esophagus and esophagogastric junction. Gastroenterology (1993) 4.23
Inflammatory pseudotumors of the lung. Ann Thorac Surg (1999) 3.51
Thoracic aortic aneurysms: a population-based study. Surgery (1982) 3.36
Gene network shaping of inherent noise spectra. Nature (2006) 3.25
Lobar torsion after pulmonary resection: presentation and outcome. J Thorac Cardiovasc Surg (2001) 3.16
Primary venous leiomyosarcoma: a rare but lethal disease. J Vasc Surg (1992) 3.05
Epiphrenic diverticulum: results of surgical treatment. Ann Thorac Surg (1993) 3.04
High short-term mortality following lung biopsy for usual interstitial pneumonia. Eur Respir J (2001) 2.67
Prevalence of Helicobacter pylori in specific forms of gastritis. Further evidence supporting a pathogenic role for H. pylori in chronic nonspecific gastritis. Dig Dis Sci (1991) 2.67
Clinical spectrum of bronchogenic cysts of the mediastinum and lung in the adult. Ann Thorac Surg (1991) 2.66
Surgical treatment of vascular rings: the Mayo Clinic experience. Mayo Clin Proc (1993) 2.63
Splenic artery aneurysms. Surgery (1982) 2.61
Menetrier's disease: a form of hypertrophic gastropathy or gastritis? Gastroenterology (1993) 2.52
Screening for lung cancer. A critique of the Mayo Lung Project. Cancer (1991) 2.47
Worldwide esophageal cancer collaboration. Dis Esophagus (2009) 2.41
Acute hepatitis E by a new isolate acquired in the United States. Mayo Clin Proc (1997) 2.36
Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst (1991) 2.35
Hamartomatous inverted polyps of the rectum. Cancer (1966) 2.30
Chest-wall reconstruction: an account of 500 consecutive patients. Plast Reconstr Surg (1996) 2.28
Colorectal lung metastases: results of surgical excision. Ann Thorac Surg (1992) 2.25
Barrett's esophagus, high-grade dysplasia, and early adenocarcinoma: a pathological study. Am J Gastroenterol (1997) 2.23
Adenocarcinoma of the esophagogastric junction and Barrett's esophagus. Gastroenterology (1995) 2.23
Postoperative chylothorax. J Thorac Cardiovasc Surg (1996) 2.19
Malakoplakia: evidence for monocyte lysosomal abnormality correctable by cholinergic agonist in vitro and in vivo. N Engl J Med (1977) 2.16
Bronchobiliary fistula: principles of management. Ann Thorac Surg (2000) 2.15
Primary chest wall tumors: factors affecting survival. Ann Thorac Surg (1986) 2.12
Hyperbaric treatment of cerebral air embolism sustained during an open-heart surgical procedure. Mayo Clin Proc (1991) 2.11
Clinical and pathologic correlation of 84 mucinous cystic neoplasms of the pancreas: can one reliably differentiate benign from malignant (or premalignant) neoplasms? Ann Surg (2000) 2.05
Pulmonary arteriovenous malformations: therapeutic options. Ann Thorac Surg (1993) 2.03
Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology (1993) 2.03
Pulmonary arteriovenous fistula: presentation, diagnosis, and treatment. World J Surg (1999) 2.01
Esophagomyotomy versus forceful dilation for achalasia of the esophagus: results in 899 patients. Ann Thorac Surg (1979) 1.92
Pervasive occult gastrointestinal bleeding in an Alaska native population with prevalent iron deficiency. Role of Helicobacter pylori gastritis. JAMA (1997) 1.89
The STS National Database: current changes and challenges for the new millennium. Committee to Establish a National Database in Cardiothoracic Surgery, The Society of Thoracic Surgeons. Ann Thorac Surg (2000) 1.85
Epidemiology of celiac sprue: a community-based study. Am J Gastroenterol (1994) 1.85
Primary non-Hodgkin's lymphoma of the lung. Ann Thorac Surg (2000) 1.83
Early and long-term results of prosthetic chest wall reconstruction. J Thorac Cardiovasc Surg (1999) 1.83
Solitary pulmonary nodules: clinical prediction model versus physicians. Mayo Clin Proc (1999) 1.81
Pulmonary alveolar phospholipoproteinosis: experience with 34 cases and a review. Mayo Clin Proc (1987) 1.78
Multiple primary lung cancers. Results of surgical treatment. J Thorac Cardiovasc Surg (1990) 1.78
Ruptured abdominal aortic aneurysms: repair should not be denied. J Vasc Surg (1992) 1.75
Penetrating atherosclerotic ulcers of the thoracic aorta: natural history and clinicopathologic correlations. Ann Vasc Surg (1986) 1.68
Esophageal resection for cancer of the esophagus: long-term function and quality of life. Ann Thorac Surg (1997) 1.68
Trends in neurovascular complications of surgical management for carotid body and cervical paragangliomas: a fifty-year experience with 153 tumors. J Vasc Surg (1988) 1.62
Serodiagnosis of Helicobacter pylori: comparison of enzyme-linked immunosorbent assays. J Clin Microbiol (1991) 1.59
Malignant melanoma of the anus: report of 12 patients and analysis of 255 additional cases. Dis Colon Rectum (1982) 1.58
Primary melanoma of the lung. Cancer (1968) 1.58
Lung volume reduction surgery for emphysema: out on a limb without a NETT. Mayo Clin Proc (1998) 1.57
Locally recurrent non-small-cell lung cancer after complete surgical resection. Mayo Clin Proc (1992) 1.57
Oxygen-exacerbated bleomycin pulmonary toxicity. Mayo Clin Proc (1991) 1.56
Autoimmune cholangitis within the spectrum of autoimmune liver disease. Hepatology (2000) 1.55
The risk of percutaneous chest tube thoracostomy for blunt thoracic trauma. Ann Emerg Med (1985) 1.51
Changing incidence of abdominal aortic aneurysms: a population-based study. Am J Epidemiol (1984) 1.50
Esophageal resection for recurrent achalasia. Ann Thorac Surg (1995) 1.49
Early gastric cancer. Br J Surg (1992) 1.49
Isolated iliac artery aneurysms. Surgery (1983) 1.49
Characteristics of plant cell walls affecting intake and digestibility of forages by ruminants. J Anim Sci (1995) 1.47
An integrated approach to evaluation of the solitary pulmonary nodule. Mayo Clin Proc (1990) 1.47
Diaphragmatic hernia and associated anemia: response to surgical treatment. J Thorac Cardiovasc Surg (1996) 1.46
Diagnosis of corticotropin-producing bronchial carcinoid tumors causing Cushing's syndrome. Mayo Clin Proc (1990) 1.46
Aortic fenestration for acute or chronic aortic dissection: an uncommon but effective procedure. J Vasc Surg (2000) 1.46
Surgical treatment of hepatic and pulmonary metastases from colon cancer. Ann Thorac Surg (2001) 1.45